TYROBP (transmembrane immune signaling adaptor TYROBP)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
7305 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Transmembrane immune signaling adaptor TYROBP |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
TYROBP |
SynonymsGene synonyms aliases
|
DAP12, KARAP, PLOSL, PLOSL1 |
ChromosomeChromosome number
|
19 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
19q13.12 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene encodes a transmembrane signaling polypeptide which contains an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic domain. The encoded protein may associate with the killer-cell inhibitory receptor (KIR) family of membrane |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs55746266 |
C>G |
Benign, conflicting-interpretations-of-pathogenicity |
Intron variant |
rs104894732 |
A>G |
Pathogenic |
Initiator codon variant, non coding transcript variant, missense variant |
rs386833839 |
C>T |
Likely-pathogenic |
Coding sequence variant, non coding transcript variant, missense variant |
rs386833840 |
C>- |
Pathogenic-likely-pathogenic |
Frameshift variant, coding sequence variant, non coding transcript variant |
rs386833841 |
C>G |
Likely-pathogenic |
Coding sequence variant, non coding transcript variant, missense variant |
rs386833842 |
C>A,T |
Likely-pathogenic |
Stop gained, coding sequence variant, non coding transcript variant, missense variant |
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0002222 |
Process |
Stimulatory killer cell immunoglobulin-like receptor signaling pathway |
IDA |
9655483 |
GO:0002223 |
Process |
Stimulatory C-type lectin receptor signaling pathway |
IDA |
9655483 |
GO:0002274 |
Process |
Myeloid leukocyte activation |
IDA |
10604985 |
GO:0002282 |
Process |
Microglial cell activation involved in immune response |
IBA |
21873635 |
GO:0002282 |
Process |
Microglial cell activation involved in immune response |
ISS |
|
GO:0002283 |
Process |
Neutrophil activation involved in immune response |
IBA |
21873635 |
GO:0005102 |
Function |
Signaling receptor binding |
IBA |
21873635 |
GO:0005102 |
Function |
Signaling receptor binding |
IPI |
11602640, 15294961 |
GO:0005102 |
Function |
Signaling receptor binding |
ISS |
29518356 |
GO:0005102 |
Function |
Signaling receptor binding |
TAS |
15601948 |
GO:0005515 |
Function |
Protein binding |
IPI |
9655483, 10049942, 10940905, 11602640, 14707061, 18624290, 26221034, 28100677, 28490631, 32296183 |
GO:0005886 |
Component |
Plasma membrane |
IDA |
|
GO:0005886 |
Component |
Plasma membrane |
TAS |
|
GO:0005887 |
Component |
Integral component of plasma membrane |
IDA |
9655483 |
GO:0006968 |
Process |
Cellular defense response |
TAS |
9490415 |
GO:0007165 |
Process |
Signal transduction |
TAS |
9490415 |
GO:0009986 |
Component |
Cell surface |
IBA |
21873635 |
GO:0009986 |
Component |
Cell surface |
IDA |
15294961 |
GO:0010628 |
Process |
Positive regulation of gene expression |
ISS |
|
GO:0016021 |
Component |
Integral component of membrane |
TAS |
15601948 |
GO:0030036 |
Process |
Actin cytoskeleton organization |
ISS |
|
GO:0030316 |
Process |
Osteoclast differentiation |
IMP |
21841309 |
GO:0030667 |
Component |
Secretory granule membrane |
TAS |
|
GO:0030889 |
Process |
Negative regulation of B cell proliferation |
IBA |
21873635 |
GO:0030889 |
Process |
Negative regulation of B cell proliferation |
IMP |
21727189 |
GO:0030900 |
Process |
Forebrain development |
ISS |
|
GO:0032693 |
Process |
Negative regulation of interleukin-10 production |
ISS |
|
GO:0032731 |
Process |
Positive regulation of interleukin-1 beta production |
ISS |
|
GO:0032755 |
Process |
Positive regulation of interleukin-6 production |
ISS |
|
GO:0032760 |
Process |
Positive regulation of tumor necrosis factor production |
ISS |
|
GO:0032816 |
Process |
Positive regulation of natural killer cell activation |
IBA |
21873635 |
GO:0032911 |
Process |
Negative regulation of transforming growth factor beta1 production |
IBA |
21873635 |
GO:0032911 |
Process |
Negative regulation of transforming growth factor beta1 production |
ISS |
|
GO:0032930 |
Process |
Positive regulation of superoxide anion generation |
ISS |
|
GO:0034241 |
Process |
Positive regulation of macrophage fusion |
IBA |
21873635 |
GO:0034241 |
Process |
Positive regulation of macrophage fusion |
IMP |
18957693 |
GO:0035556 |
Process |
Intracellular signal transduction |
TAS |
9490415 |
GO:0042802 |
Function |
Identical protein binding |
IPI |
20890284 |
GO:0042803 |
Function |
Protein homodimerization activity |
IDA |
9655483 |
GO:0043277 |
Process |
Apoptotic cell clearance |
ISS |
|
GO:0043312 |
Process |
Neutrophil degranulation |
TAS |
|
GO:0045087 |
Process |
Innate immune response |
TAS |
|
GO:0046872 |
Function |
Metal ion binding |
IEA |
|
GO:0048678 |
Process |
Response to axon injury |
ISS |
|
GO:0050776 |
Process |
Regulation of immune response |
TAS |
|
GO:0050821 |
Process |
Protein stabilization |
IDA |
25957402 |
GO:0050821 |
Process |
Protein stabilization |
IMP |
23715743 |
GO:0097190 |
Process |
Apoptotic signaling pathway |
ISS |
|
GO:0110090 |
Process |
Positive regulation of hippocampal neuron apoptotic process |
ISS |
|
GO:1900272 |
Process |
Negative regulation of long-term synaptic potentiation |
ISS |
|
GO:1901216 |
Process |
Positive regulation of neuron death |
ISS |
|
GO:1902685 |
Process |
Positive regulation of receptor localization to synapse |
ISS |
|
GO:1904151 |
Process |
Positive regulation of microglial cell mediated cytotoxicity |
IBA |
21873635 |
GO:1904151 |
Process |
Positive regulation of microglial cell mediated cytotoxicity |
ISS |
|
GO:2000010 |
Process |
Positive regulation of protein localization to cell surface |
IMP |
23715743 |
GO:2001206 |
Process |
Positive regulation of osteoclast development |
ISS |
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
O43914 |
Protein name |
TYRO protein tyrosine kinase-binding protein (DNAX-activation protein 12) (Killer-activating receptor-associated protein) (KAR-associated protein) |
Protein function |
Adapter protein which non-covalently associates with activating receptors found on the surface of a variety of immune cells to mediate signaling and cell activation following ligand binding by the receptors (PubMed:10604985, PubMed:9490415, PubM |
PDB |
2L34
,
2L35
,
4WO1
,
4WOL
,
7Q5W
|
Family and domains |
|
Sequence |
MGGLEPCSRLLLLPLLLAVSGLRPVQAQAQSDCSCSTVSPGVLAGIVMGDLVLTVLIALA VYFLGRLVPRGRGAAEAATRKQRITETESPYQELQGQRSDVYSDLNTQRPYYK
|
|
Sequence length |
113 |
Interactions |
View interactions |
PathwaysPathway information has different metabolic/signaling pathways associated with genes. Each record is hyperlinked to a complete information page which also includes links to the KEGG/Reactome pathway database.
|
|
Associated diseases
|
Causal |
Disease name |
Disease term |
dbSNP ID |
References |
Apraxia |
Apraxias |
rs121908377, rs121908378, rs1135401820, rs1178491246, rs1584969672 |
|
Developmental regression |
Developmental regression |
rs1224421127 |
|
Hydrocephalus |
Hydrocephalus |
rs387907320, rs369384363, rs387907321, rs372127610, rs770273135, rs797045095, rs797045707, rs769795916, rs781251438, rs922703465, rs376078512, rs1567043467, rs1587149916, rs1586841546 |
|
Leukemia |
Acute leukemia |
rs121909646, rs121913488, rs587776834, rs752746786, rs869312821, rs767454740, rs1554564297, rs11978267, rs4132601 |
|
Leukoencephalopathy |
Leukoencephalopathy |
rs34757931 |
|
Osteochondrodysplasia |
Osteochondrodysplasias |
rs386833498, rs104893919, rs104893916, rs386833492, rs121908078, rs386833497, rs386833507, rs200963884, rs121908077, rs786204675, rs763198695, rs1554095433, rs766836061 |
|
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY, POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 1 |
rs104893998, rs104894001, rs121908402, rs104894002, rs104894732, rs386833839, rs386833840, rs386833842, rs386834140, rs386834141, rs386834142, rs386834143, rs386834144, rs201258663, rs797044603 |
12370476, 10888890, 24357685 |
Skeletal dysplasia |
Skeletal dysplasia |
rs121912632, rs121912633, rs121912634, rs121912636, rs121912637, rs267607147, rs387906324, rs267607150, rs397514473, rs398123438, rs515726153, rs515726154, rs515726162, rs515726163, rs515726172, rs757011098 |
|
|
Unknown |
Disease name |
Disease term |
dbSNP ID |
References |
Agnosia |
Agnosia |
|
|
Cerebral atrophy |
Cerebral atrophy |
|
|
Cerebral cortical atrophy |
Cerebral cortical atrophy |
|
|
Dementia |
Dementia |
|
10888890, 15049507 |
Dementia of frontal lobe |
Dementia of frontal lobe type |
|
|
Hypoplasia of corpus callosum |
Hypoplasia of corpus callosum |
|
|
Nasu-hakola disease |
Nasu-Hakola disease |
|
|
Oculomotor apraxia |
Oculomotor apraxia |
|
|
Oculovestibuloauditory syndrome |
Oculovestibuloauditory syndrome |
|
|
Speech disorders |
Speech Disorders |
|
|
|
|
|